At Health Datapalooza, the Acting Centers for Medicare & Medicaid Services (CMS) Administrator Andy Slavitt announced a new policy that will allow innovators and entrepreneurs to access CMS data, such as Medicare claims. Under the policy, those interested may conduct approved research that will ultimately improve care and provide better tools that should benefit healthcare consumers through a greater understanding of what the data says works best in healthcare. The data will not allow the patient's identity to be determined, but will provide the identity of the providers of care. CMS will begin accepting innovator research requests in September 2015.
For years, the radiology industry has focused on reducing, or eliminating patient exposure to radiation. Recently, the industry has shifted attention to the cumulative effect radiation exposure has over the course of a physician’s career.
Penumbra Inc. announced that the company’s ACE64 aspiration thrombectomy system received 510(k) marketing clearance from the U.S. Food and Drug Administration for the revascularization of large vessel occlusions in patients with acute ischemic stroke.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
REVA Medical Inc. announced the initiation of patient enrollment in the FANTOM II clinical trial of its Fantom sirolimus-eluting bioresorbable scaffold in March. The scaffold, made from REVA's advanced proprietary polymer, is designed to allow the restoration of blood flow in patients being treated for coronary artery disease, then resorb from the body over time.
Health and Human Services Secretary Sylvia M. Burwell announced an opportunity for healthcare providers to decrease cardiovascular disease risk for Medicare beneficiaries through a new payment model. Using the model, providers can assess an individual patient’s risks for heart attack or stroke and work with them to reduce those risks. Secretary Burwell made the announcement at the White House Conference on Aging regional forum in Boston.
Medtronic announced the launch of the Euphora semicompliant balloon dilatation catheter in countries that recognize the CE (Conformité Européene) mark in February. The first patient case with the Euphora was performed in the same month by Richard Edwards, M.D., consultant cardiologist at the Freeman Hospital in Newcastle, United Kingdom.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Researchers from the University of Chicago and Stanford University combed through scientific literature on the pharmacogenomics of 71 leading cardiovascular drugs to help physicians better understand how genetic variations can affect patient response. The researchers compiled summaries of the information, published in the June issue of the Mayo Clinic Proceedings, to help physicians make better-informed clinical decisions about these drugs.
Beaumont Hospital, Royal Oak is one of the first centers in the United States to use a new minimally invasive heart pump designed to provide temporary support for patients with severe right-side heart failure.
Bracco Imaging announced that the first echocardiography imaging procedure with Lumason was performed in May at Morristown Medical Center, part of the Atlantic Health System, in New Jersey. This is the first administration after the development of the agent (sulfur hexafluoride lipid-type A microspheres) in the United States and approval by the U.S. Food and Drug Administration. The announcement was made through Bracco Imaging’s affiliate Bracco Diagnostics Inc.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Toshiba's new Assurance 360 program is making it easier for existing computed tomography (CT) customers to lower radiation dose, improve their scanners' performance and achieve compliance with the MITA Smart Dose standard (XR-29). Assurance 360 not only updates a system to XR-29 compliant but takes patient safety a step further with dose reduction technology and the training and support needed to become dose efficient.
Using tools that help physicians decide whether to use expensive imaging studies can help reduce the ordering of unnecessary tests, but implementation in real-world settings has many challenges, according to a new RAND Corp. study.
One year after the adoption of the Affordable Care Act (ACA), a new study by Health eCareers found that the effect of the ACA’s new policies ranked as the third most pressing concern for healthcare recruiters and hiring managers, just behind staff turnover and the projected physician shortage.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Percutaneous Cardiovascular Solutions (PCS) announced it had been granted a key patent in the United States covering its percutaneous mitral valve replacement system.
Merit Medical Systems Inc. announced the launch of the Prelude Snap splittable sheath introducer.
GE Healthcare introduced a new in-field upgrade program for 1.5T magnetic resonance imaging (MRI) systems in most regions globally. A currently installed GE Healthcare 1.5T LCC magnet may be upgraded to the new Signa Explorer Lift so customers can benefit from the modernized patient comfort, workflow efficiency and diagnostic quality of this system. By upgrading, customers can potentially benefit from cost savings in multiple ways: up to 50 percent savings in construction cost, up to 50 percent savings in equipment cost in comparison to a new 1.5T system, and up to 30 percent increase in procedures due to potential increased throughput and referrals.